You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

86 Results
Drug
Other Name(s): Lanvis®
Jun 2019
Drug
Other Name(s): Zolinza®
Jun 2019
Drug
Other Name(s): Adcetris®
Jun 2025
Drug
Other Name(s): Tafinlar®
Jun 2025
Drug
Other Name(s): Mekinist®
Jun 2025
Drug
Other Name(s): Ninlaro™
Jun 2019
Drug
Other Name(s): Rydapt®
Jun 2025
Regimen
Cancer Type:
Sarcoma, 
Soft Tissue, 
Skin, 
Melanoma
Intent: Palliative
Jun 2025
Regimen
Cancer Type:
Gynecologic, 
Gestational Trophoblastic Disease
Intent: Curative
Jun 2019
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Jun 2019
Regimen
Cancer Type:
Sarcoma, 
Ewing's, 
Soft Tissue
Intent: Neoadjuvant, Adjuvant, Palliative
Jun 2019
Regimen
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Funding:
ODB - General Benefit
    melphalan - oral tablets
ODB - General Benefit
    prednisone
Jun 2019

Pages